513 results on '"Nakanishi, Yoichi"'
Search Results
2. Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers
3. Nab-Paclitaxel for Previously Treated Advanced Non–Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment
4. A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
5. Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC
6. Quantification of HER family dimers by proximity ligation assay and its clinical evaluation in non–small cell lung cancer patients treated with osimertinib
7. Characteristics of tobacco-related lung diseases in Fukuoka Prefecture, Japan: A prospective, multi-institutional, observational study
8. Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy
9. Incense smoke-induced oxidative stress disrupts tight junctions and bronchial epithelial barrier integrity and induces airway hyperresponsiveness in mouse lungs
10. Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events
11. Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission
12. Safety and efficacy of brilliant blue g250 (BBG) for lens capsular staining: a phase III physician-initiated multicenter clinical trial
13. Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors
14. Preclinical Toxicity Studies for Regenerative Medicine in Japan
15. Anticancer drug treatment for advanced lung cancer with interstitial lung disease
16. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers
17. Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
18. Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients
19. A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma
20. Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37
21. Molecular Cloning of Vacuolar H⁺-Pyrophosphatase and Its Developmental Expression in Growing Hypocotyl of Mung Bean
22. A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L
23. Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
24. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial
25. 18F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer
26. Hypermethylation of the CpG dinucleotide in epidermal growth factor receptor codon 790: implications for a mutational hotspot leading to the T790M mutation in non–small-cell lung cancer
27. Prevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: The Hisayama Study
28. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: The Hisayama study
29. Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan
30. FRET-based detection of isozyme-specific activities of transglutaminases
31. Longitudinal assessment of pain management with the pain management index in cancer outpatients receiving chemotherapy
32. Population pharmacokinetic–pharmacodynamic modeling and model-based prediction of docetaxel-induced neutropenia in Japanese patients with non-small cell lung cancer
33. Current status and future perspectives of cooperative study groups for lung cancer in Japan
34. Surgery for Small Cell Lung Cancer: A Retrospective Analysis of 243 Patients from Japanese Lung Cancer Registry in 2004
35. Retrospective analysis of nursing and healthcare-associated pneumonia: Analysis of adverse prognostic factors and validity of the selection criteria
36. Genetic polymorphisms involved in the inflammatory response and lung cancer risk: A case-control study in Japan
37. Purification of zebrafish erythrocytes as a means of identifying a novel regulator of haematopoiesis
38. World Lung Day 2023—Access to prevention and treatment for all, leave no one behind.
39. Periodontal status and lung function decline in the community: the Hisayama study
40. Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis
41. Core regulatory components of the PHO pathway are conserved in the methylotrophic yeast Hansenula polymorpha
42. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan
43. Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes
44. Expression of cytokine and extracellular matrix mRNAs in fetal hepatic stellate cells
45. Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
46. Absence of LTB4/BLT1 axis facilitates generation of mouse GM-CSF–induced long-lasting antitumor immunologic memory by enhancing innate and adaptive immune systems
47. A Phase I Study of Chemoradiotherapy With Use of Involved-Field Conformal Radiotherapy and Accelerated Hyperfractionation for Stage III Non-Small Cell Lung Cancer: WJTOG 3305
48. Identifying risk factors for refractory febrile neutropenia in patients with lung cancer
49. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease
50. The clinical efficacy and safety of micafungin–itraconazole combination therapy in patients with pulmonary aspergilloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.